12 Health Care Stocks Moving In Friday's Intraday Session

BenzingaOct 26 00:31

Zenas Started at Buy by Four Banks on Lead Drug Potential

Seeking AlphaOct 9 03:05

A Quick Look at Today's Ratings for Zenas BioPharma(ZBIO.US), With a Forecast Between $27 to $40

Futu NewsOct 8 21:00 · Ratings

Zenas BioPharma Initiated at Overweight by Morgan Stanley

Dow JonesOct 8 19:33 · Ratings

Zenas BioPharma Price Target Announced at $40.00/Share by Morgan Stanley

Dow JonesOct 8 19:33 · Ratings

Guggenheim Initiates Coverage On Zenas BioPharma With Buy Rating, Announces Price Target of $45

BenzingaOct 8 17:46 · Ratings